SOUTH
PLAINFIELD, N.J., July 20,
2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:
PTCT) today announced that the company will host a webcast
conference call to report its second quarter 2023 financial results
and provide an update on the company's business and outlook on
Thursday, Aug. 3, at 4:30 p.m. ET.
To access the call by phone, please click here to register and
you will be provided with dial-in details. To avoid delays, we
recommend participants dial in to the conference call 15 minutes
prior to the start of the call. The webcast conference call can be
accessed on the Investor section of the PTC website at
https://ir.ptcbio.com/events-presentations. A replay of the call
will be available approximately two hours after completion
of the call and will be archived on the company's website for
30 days following the call.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company focused on the discovery,
development and commercialization of clinically differentiated
medicines that provide benefits to patients with rare disorders.
PTC's ability to globally commercialize products is the foundation
that drives investment in a robust and diversified pipeline of
transformative medicines and our mission to provide access to
best-in-class treatments for patients who have an unmet medical
need. The Company's strategy is to leverage its strong scientific
expertise and global commercial infrastructure to maximize value
for its patients and other stakeholders. To learn more about PTC,
please visit us at www.ptcbio.com and follow us on Instagram,
Facebook, Twitter, and LinkedIn.
For More Information:
Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-second-quarter-2023-financial-results-301881437.html
SOURCE PTC Therapeutics, Inc.